ICON Insights
BioPharma companies and Medical Device manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
Thought leadership
- Digital Disruption加速和改善临床试验的技术。
- 患者为中心Patients are now better informed on clinical options than they ever have been.
- 监管智力Regulatory experts partnering with you.
- Therapeutics insightsThought leadership from ICON's global team of therapeutic experts.
- 转型试验传统的临床发展模式需要改变。
- 基于价值的开发传统的医疗保健交付模式正在发生变化。
Digital Disruption
加速和改善临床试验的技术。
患者为中心
Patients are now better informed on clinical options than they ever have been.
监管智力
Regulatory experts partnering with you.
Therapeutics insights
Thought leadership from ICON's global team of therapeutic experts.
转型试验
传统的临床发展模式需要改变。
基于价值的开发
传统的医疗保健交付模式正在发生变化。
Insight topics
Risk Based Quality Management
强大的风险分析和评估审查应决定监测策略，需要对所有研究进行。
细胞和基因治疗临床试验
The promise and complexity of living therapies.
The evolution of HIV treatments
From antiretroviral therapy to vaccines, where we are today and what’s next.
ICER’s impact on payer decision making
图标第三次年度调查结果。
The IVDR journey
达到2022年截止日期的路线图，同时导航大流行中断。
利用罕见疾病试验的历史数据
了解贝叶斯和频繁的方法。
美国付款人依赖于覆盖作品的患者报告的结果
Current views and future outlook.
敏捷临床监测
The flexibility to keep your trials on track.
Challenges and opportunities in traumatic brain injury clinical trials
从识别生物标志物以提高临床试验效率。
Patient centricity in orphan drug development
正规患者参与稀有疾病毒药发展的分析。
Mitigating the impact of COVID-19 on cardiovascular trials
在全球大流行期间确保患者的安全和审判诚信。
患者为中心
Exploring the patient dynamic from different perspectives.
Advancing digital endpoints
An end-to-end approach to managing wearable devices through clinical development.
生物统计学 - 将清晰度和重点关注研究问题：估计的作用
了解有关估价值的更多信息以及部署此方法将如何提高临床研究质量。
COVID-19: Navigating global market access requirements
最大限度地提高HTA成功的见解。
病人语音调查 - 分散和混合试验
The patient perspective.
大流行呼吸疫苗临床试验
在世界等待时加速业务的最佳实践。
分散和混合试验
图标通过其全球网站网络进行了调查，以获得患者视图。
付款人对数字治疗的观点bob体育网站
深入的访谈揭示了美国付款人所需的制造商。
Outsourced pharmacovigilance affiliate solution
为什么外包药物知识在联盟级别进行了意义
难以忘怀Patient-Centricity与互联网of Medical Things (IoMT)
Discover how emerging technologies can increase clinical trial efficiency
数字技术如何改变研发生产力
利用数字技术的力量。
在药物开发中提高复杂性和ROI下降
来自高级制药高管的透视
Flow Cytometry for Driving Trials Forward
Engage assay experts with unparalleled experience and expertise
Impact of Artificial Intelligence on Outcomes Based Contracting
Understanding the challenges for formulary decision makers and manufacturer
Key Considerations in Chronic Pain Clinical Trials
Determine the right design, assessments and endpoints in your pain study
MDR/IVDR brings higher costs and bottlenecks
开发合适的业务策略以成功导航MDR / IVDR
ICER作为一个独立的HTA组织的作用
primary research evaluating ICER’s influence over payers and manufactures
药物安全报告
通过自动化提高效率
Personalising Digital Health
开发一个综合的患者为中心的方法来利用数字健康技术
理解生物仿制性市场
Get the insights you need for successful biosimilar commercialisation
调查员付款
全球调查员付款解决方案
监管情报通讯
ICON’s monthly Regulatory Intelligence Newsletter
CDISC数据标准化
Legacy Data Conversion
可穿戴设备
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
自适应设计：市场的速度更快
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.